Evidence map›Paper›PMID 31531679›Full record

ArticleCellular and molecular life sciences : CMLS2020

Evidence for miR-548c-5p regulation of FOXC2 transcription through a distal genomic target site in human podocytes.

Andrea Christofides, Gregory Papagregoriou, Harsh Dweep, Neoklis Makrides, Norbert Gretz, Kyriacos Felekkis, Constantinos Deltas

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in cell and developmental biology · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Andrea ChristofidesMolecular Medicine Research Center and Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
Gregory PapagregoriouMolecular Medicine Research Center and Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus. papagregoriou@ucy.ac.cy.ORCID http://orcid.org/0000-0002-2440-9789
Harsh DweepThe Wistar Institute, 3601 Spruce St, Philadelphia, PA, 19104, USA.
Neoklis MakridesDevelopmental and Functional Genetics Group, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Norbert GretzMedical Research Center, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.
Kyriacos FelekkisDepartment of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
Constantinos DeltasMolecular Medicine Research Center and Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus. deltas@ucy.ac.cy.
University of Cyprus · CYCyprus Institute of Neurology and Genetics · CYHeidelberg University · DEThe Wistar Institute · USUniversity of Nicosia · CY

Funding

Research Promotion Foundation Strategic Infrastructure Project NEW INFRASTRUCTURE/STRATEGIC/ 0308/24
6 · The paper itself

Abstract

Podocytes are highly differentiated epithelial cells outlining the glomerular vessels. FOXC2 is a transcription factor essential for inducing podocyte differentiation, development and maturation, and is considered to be the earliest podocyte marker. miRNA prediction analysis revealed a full-length target site for the primate-specific miR-548c-5p at a genomic region > 8 kb upstream of FOXC2. We hypothesised that the transcription rates of FOXC2 during podocyte differentiation might be tuned by miR-548c-5p through this target site. Experiments were performed with cultured human podocytes, transfected with luciferase reporter constructs bearing this target site region within an enhancer element of the native plasmid. The results confirmed a seed region-driven targeting potential by the miRNA, with mimics downregulating and inhibitors enhancing luciferase activity. Introducing mutations into the miRNA target seed region abolished the expected response. In cultured podocytes, FOXC2 mRNA and protein levels responded to miR-548c-5p abundance in a coordinated manner before and after induction of differentiation, with high statistical significance. Ago-ChIP experiments revealed occupancy of the miRNA target site by miRNA/RISC in undifferentiated cells and its release when differentiation is initiated, allowing its interaction with the gene's promoter region to amplify FOXC2 expression, as shown by chromosome conformation capture and qRT-PCR. Moreover, the expression pattern of FOXC2 during podocyte differentiation seems to be affected by miR-548c-5p, as removal of either endogenous or mimic miR-548c-5p results in increased FOXC2 protein levels and cells resembling those undergoing differentiation. Collectively, results indicate a well-orchestrated regulatory model of FOXC2 expression by a remote upstream target site for miR-548c-5p.

Indexed as

Base SequenceCell DifferentiationCell LineDown-RegulationForkhead Transcription FactorsGene Expression RegulationGenomicsHEK293 CellsHumansMicroRNAsPodocytesRNA, MessengerTranscription, GeneticForkhead Transcription Factorsmesenchyme fork head 1 proteinMicroRNAsMIRN548 microRNA, humanRNA, MessengerDifferentiationEnhancerMADE1microRNAMIR-548 familyPrimate specificPromoterRepressor

Identifiers

PMID31531679
PMCPMC11105105
OpenAlexW2974223323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.